Boston Scientific BSX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 69.2%+0.1pp | 69%+0.4pp | 68.6%+0.3pp | 68.3%-0.4pp | 68.7%+0.1pp | |
| Operating margin | 18.4%+0.4pp | 18%+0.1pp | 17.9%+0.9pp | 17%+0.8pp | 16.2%+0.7pp | |
| Net margin | 17.3%+2.9pp | 14.4%0.0pp | 14.4%+0.9pp | 13.5%+2.0pp | 11.5%+0.5pp | |
| Returns | ||||||
| Return on equity | 14.8%+2.2pp | 12.6%-0.1pp | 12.6%+1.0pp | 11.7%+2.1pp | 9.6%+0.6pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.9×+0.3× | 1.6×+0.1× | 1.5×+0.1× | 1.4×-0.1× | 1.5×+0.4× | |
| Per Share | ||||||
| Book value per share | $17.30+6.7% | $16.21+3.7% | $15.64+4.2% | $15.01+0.9% | $14.88+1.5% | |
| Valuation | ||||||
| Market capitalization | $93.26B-34.0% | $141.35B-2.3% | $144.66B-6.1% | $154.04B+3.2% | $149.21B+13.3% | |
| Price / earnings | 26.2×-22.7× | 48.9×-3.1× | 52×-9.7× | 61.7×-12.0× | 73.7×+2.4× | |
| Price / sales | 4.5×-2.5× | 7×-0.4× | 7.5×-0.9× | 8.3×-0.2× | 8.5×+0.6× | |
| Price / book | 3.6×-2.2× | 5.8×-0.4× | 6.2×-0.7× | 6.9×+0.2× | 6.7×+0.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Boston Scientific's profit margins?
- Boston Scientific (BSX) runs a 69.2% gross margin and a 18.4% operating margin, with a 17.3% net margin.
- Where do Boston Scientific's ratios come from?
- Every ratio is computed from Boston Scientific's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
